Armata Pharmaceuticals (ARMP) Stock: Buy, Sell, or Hold?
ARMP - Armata Pharmaceuticals, Inc. Common Stock
$3.64
0.19 (5.51%)
â˛
5d:
+8.01%
30d:
+0.55%
90d:
-29.32%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 11, 2026
18d
Get Alerted When ARMP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ARMP is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ARMP is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: ARMP is currently trading at $3.64, which is considered fair relative to its 30-day fair value range of $3.17 to $4.21.
Technical Outlook: Technically, ARMP is in a strong downtrend. Immediate support is located at $2.75, while resistance sits at $3.84. The stock is showing strong short-term momentum, up 5.5% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $17.50 (+380.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ARMP is in a strong downtrend. Immediate support is located at $2.75, while resistance sits at $3.84. The stock is showing strong short-term momentum, up 5.5% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $17.50 (+380.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.17 -
$4.21
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.5%)
- BULLISH: Trading 380.8% below Wall St target ($17.50)
- WARNING: Composite score 42/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.17 -
$4.21
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.75
Resistance Level
$3.84
Current Trend
Strong Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.52
Wall Street Target
$17.50
(+380.8%)
Revenue Growth (YoY)
15.7%
Share & Embed Analysis
Last updated: October 23, 2026 5:11 PM ET
Data refreshes hourly during market hours. Next update: 6:11 PM
Data refreshes hourly during market hours. Next update: 6:11 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARMP showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$258 | 61 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$72 | 48 HOLD |
